Evidence map›Paper›PMID 22237625›Full record

ArticleCancer research2012

Pocket proteins suppress head and neck cancer.

Myeong-Kyun Shin, Henry C Pitot, Paul F Lambert

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. TMEM16A as a potential treatment target for head and neck cancer.Journal of experimental & clinical cancer research : CR · 2022
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Activating Mutations inClinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  9. Article
  10. Article
  11. Skin Tumors Rb(eing) Uncovered.Frontiers in oncology · 2013
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Myeong-Kyun ShinMcArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53706, USA.
Henry C Pitot
Paul F Lambert
University of Wisconsin–Madison · US

Funding

Visualizing EBV and HCMV DNA Dynamics During InfectionP01CA022443 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WILLIAM M. SUGDEN · 1985 to 2026
$53.1M
Functional Analysis of the HPV-16 E6 and E7 OncogenesR01CA098428 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2003 to 2012
$3.7M
Mouse Model for Human Papillomaviral (HPV)-associated Oral CancerR01DE017315 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2006 to 2010
$1.7M
NCI NIH HHS CA022443NCI NIH HHS P01 CA022443NCI NIH HHS R01 CA098428NIDCR NIH HHS DE017315NIDCR NIH HHS R01 DE017315
6 · The paper itself

Abstract

Head and neck squamous cell carcinomas (HNSCC) is a common cancer in humans long known to be caused by tobacco and alcohol use, but now an increasing percentage of HNSCC is recognized to be caused by the same human papillomaviruses (HPV) that cause cervical and other anogenital cancers. HPV-positive HNSCCs differ remarkably from HPV-negative HNSCCs in their clinical response and molecular properties. From studies in mice, we know that E7 is the dominant HPV oncoprotein in head and neck cancer. E7 is best known for its ability to inactivate pRb, the product of the retinoblastoma tumor susceptibility gene. However, loss of pRb function does not fully account for potency of E7 in causing head and neck cancer. In this study, we characterized the cancer susceptibility of mice deficient in the expression of pRb and either of two related "pocket" proteins, p107 and p130, that are also inactivated by E7. pRb/p107-deficient mice developed head and neck cancer as frequently as do HPV-16 E7 transgenic mice. The head and neck epithelia of the pRb/p107-deficient mice also displayed the same acute phenotypes and biomarker readouts as observed in the epithelia of E7 transgenic mice. Mice deficient for pRb and p130 in their head and neck epithelia showed intermediate acute and tumor phenotypes. We conclude that pRb and p107 act together to efficiently suppress head and neck cancer and are, therefore, highly relevant targets of HPV-16 E7 in its contribution to HPV-positive HNSCC.

Indexed as

AnimalsCarcinoma, Squamous CellCrk-Associated Substrate ProteinHead and Neck NeoplasmsHuman papillomavirus 16HumansMiceMice, TransgenicPapillomaviridaePapillomavirus E7 ProteinsRepressor ProteinsRetinoblastoma-Like Protein p107Retinoblastoma ProteinSquamous Cell Carcinoma of Head and NeckBCAR1 protein, humanCrk-Associated Substrate ProteinPapillomavirus E7 ProteinsRepressor ProteinsRetinoblastoma-Like Protein p107Retinoblastoma Protein

Identifiers

PMID22237625
PMCPMC3293996
OpenAlexW2083191282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.